Search Results 2831-2840 of 14840 for Venlafaxine

1. Trial of Eflornithine Plus Sulindac in Patients with Familial Adenomatous Polyposis (FAP) - Mayo Clinic

   This includes: 1) FAP related disease progression indicating the need for excisional intervention involving the colon, rectum, pouch, duodenum and/or 2) ...

2. Patient Stories - Theresa N. Kinard, M.D. - Mayo Clinic

   Your gift holds great power – donate today! ... Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.

3. A Study to Evaluate Human Intervention Motivation - Mayo Clinic

   The purpose of this study is to provide the first descriptive analysis of a long-standing HIMS program implementation. Chemical dependency among pilots has been ...

4. Long-term Outcomes of a Clinical Ketamine Service for Treatment-resistant Depression

   We hypothesize that patients who have a greater number of infusions/treatments will be more likely to have increased side effects to the drug. We would like to ...

5. A Study to Evaluate Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant - Mayo Clinic

   About this study. The purpose of this study is test the hypothesis that plasmapheresis plus rituximab prior to or shortly after kidney transplantation can ...

6. A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL) - Mayo Clinic

   The purpose of this study is to evaluate the Maximum Tolerated Dose (MTD) of pralatrexate in combination with cyclophosphamide, doxorubicin, vincristine, and ...

7. Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes - Mayo Clinic

   This study will compare the effect of semaglutide (a new medicine) compared to "dummy" medicine on body weight and heart failure symptoms. Participants will ...

8. Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML) - Mayo Clinic

   About this study. Phase I Dose Escalation: To investigate the MTD, safety, efficacy and pharmacokinetics of volasertib in combination with decitabine in ...

9. BCL2 Inhibitor Venetoclax With Daratumumab-Lenalidomide-Dexamethasone Or Venetoclax-Rd for Newly Diagnosed Multiple Myeloma - Mayo Clinic

   The purpose of this study is to estimate the recommended phase II dose (RP2D) of venetoclax that can be combined with standard dose Dd combination (Arm A), Rd ...

10. A Study to Evaluate Patient Perspectives of Vaginal Bleeding During the Menopause Transition and Future Innovations Addressing Changes in Vaginal Bleeding Patterns - Mayo Clinic

    The primary purpose of this study is to assess how women within different stages of menopause perceive menstrual bleeding changes during the menopause ...